Dr. Eric Kozfkay of Michigan Pain Consultants recently spoke on the topic of Regenerative Medicine at a public seminar on the campus of Metro Health in Wyoming, Michigan. In the event you were unable to be in attendance, we are please to be able to provided this video Dr. Kozfkay’s full presentation.
Today, a rapidly growing number of chronic pain patients who have not responded to conventional therapies are reporting life changing results after undergoing a series of low dose ketamine infusion treatments. Research over the course of the last 15 years has shown that small doses of intravenous ketamine infusions have been effective in decreasing symptoms related to chronic pain syndromes, especially those that have a neuropathic component.
If you or someone you know is effected by arthritis, please join us this Saturday June 10, 2017 for the Arthritis Foundation Living with Arthritis Expo. The event will be held from 8:30am-12:15pm at the Spartan Stores YMCA located at:
5722 Metro Way
Wyoming, MI 49519
Dr. Joe Vanden Bosch will be presenting on Pain Mechanisms and Types of Arthritis. Dr. Eric Kozfkay will be presenting on Regenerative Medicine treatment options available for arthritic conditions.
Michigan Pain Consultants agrees to be part of FDA trial to develop oral version of drug.
October 14, 2016 | By Charlsie Dewey | grbj.com
According to Dr. Mark Gostine, co-founder of Michigan Pain Consultants, chronic pain and depression go hand in hand, which is why 40 to 50 percent of his practice’s patients are on anti-depressants. Michigan Pain Consultants provides intravenous Ketamine treatments for depression, and recently signed on to be part of an FDA trial for an oral ketamine drug developed by Naurex, who was recently purchased by Allegan Pharmaceutical.